Hikma Pharmaceuticals (H5P) Ownership - Who Owns Hikma Pharmaceuticals?
Hikma Pharmaceuticals (H5P) Ownership Overview
- 12.11% Insiders
- 8.09% Mutual Funds
- 7.52% ETFs
- 72.28% Public Companies and Individual Investors
The ownership structure of Hikma Pharmaceuticals (DE:H5P) stock is a mix of institutional, retail, and individual investors. Approximately 15.61% of the company’s stock is owned by Institutional Investors, 12.11% is owned by Insiders, and 72.28% is owned by Public Companies and Individual Investors.
The ownership structure of Hikma Pharmaceuticals (DE:H5P) stock is a mix of institutional, retail, and individual investors. Approximately 15.61% of the company’s stock is owned by Institutional Investors, 12.11% is owned by Insiders, and 72.28% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 10, 2026 | Tobias Hestler | £123,600 | |
| Jun 01, 2026 | Susan Ringdal | £553,837 | |
| Apr 27, 2026 | Victoria Mary Hull | £198,901 | |
| Apr 12, 2026 | Julie Hill | £40,854 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Said Darwazah | 15,045,939 | Insider | 7.21% | 344,281,176 |
| Mazen Darwazah | 8,969,050 | Insider | 4.30% | 205,229,802 |
| Vanguard | 6,865,342 | Institution | 3.29% | 157,092,756 |
| Ishares | 3,377,035 | Institution | 1.62% | 77,273,315 |
| Hartford Mutual Funds, Inc | 3,055,645 | Institution | 1.46% | 69,919,269 |
| Vanguard Specialized Funds | 2,567,787 | Institution | 1.23% | 58,756,102 |
| Vanguard Star Funds | 2,171,048 | Institution | 1.04% | 49,677,920 |
| John Hancock Investment Trust | 1,984,278 | Institution | 0.95% | 45,404,249 |
| Vanguard Tax-managed Funds | 1,436,142 | Institution | 0.69% | 32,861,801 |
| Dimensional | 1,175,519 | Institution | 0.56% | 26,898,226 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Hartford Mutual Funds, Inc | 3,055,645 | Institution | 1.46% | 69,919,269 |
| Vanguard Specialized Funds | 2,567,787 | Institution | 1.23% | 58,756,102 |
| Vanguard Star Funds | 2,171,048 | Institution | 1.04% | 49,677,920 |
| John Hancock Investment Trust | 1,984,278 | Institution | 0.95% | 45,404,249 |
| Vanguard Tax-managed Funds | 1,436,142 | Institution | 0.69% | 32,861,801 |
| Vanguard International Equity Index Funds | 1,029,943 | Institution | 0.49% | 23,567,156 |
| Dfa Investment Dimensions Group Inc | 831,249 | Institution | 0.40% | 19,020,640 |
| John Hancock Variable Insurance Trust | 540,373 | Institution | 0.26% | 12,364,815 |
| Vanguard Whitehall Funds | 402,084 | Institution | 0.19% | 9,200,486 |
| Tiaa-cref Funds | 370,305 | Institution | 0.18% | 8,473,319 |
FAQ
What percentage of Hikma Pharmaceuticals (DE:H5P) stock is held by retail investors?
According to the latest TipRanks data, approximately 72.28% of Hikma Pharmaceuticals (DE:H5P) stock is held by retail investors.
Who owns the most shares of Hikma Pharmaceuticals (DE:H5P)?
Said Darwazah owns the most shares of Hikma Pharmaceuticals (DE:H5P).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.